Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access                       
ValueForum.com Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain BAX message board posts where the ticker symbol BAX has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest BAX SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001645572-18-000007 Size: 12 KB
2018-09-19
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001678067-18-000005 Size: 12 KB
2018-09-19
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001678065-18-000005 Size: 4 KB
2018-09-05
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001712314-18-000002 Size: 4 KB
2018-09-05
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001715790-18-000002 Size: 4 KB
2018-09-05
S-3ASR  Documents Automatic shelf registration statement of securities of well-known seasoned issuers
Acc-no: 0001193125-18-256363 (33 Act)  Size: 497 KB
2018-08-23 333-226987
181035176
8-K  Documents   Interactive Data Current report, items 8.01 and 9.01
Acc-no: 0001564590-18-022264 (34 Act)  Size: 30 MB
2018-08-23 001-04448
181034942
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001220966-18-000004 Size: 5 KB
2018-08-13
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001360147-18-000004 Size: 5 KB
2018-08-13
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001206256-18-000004 Size: 9 KB
2018-08-10
More BAX SEC Filings


Related news from
Thu, 18 Oct 2018
14:35:02 +0000
What Analysts Expect for Boston Scientific Stock
Of the total 25 analysts covering Boston Scientific (BSX) in October 2018, 22 analysts have given Boston Scientific a “buy” or higher rating, and three analysts have given Boston Scientific a “hold” rating. The mean rating for Boston Scientific is 1.52 with a target price of $41.57, which implies an upside potential of 9.4% over Boston Scientific’s closing price of $38.0 on October 17, 2018.
Thu, 18 Oct 2018
14:03:43 +0000
What Will BSX’s Q3 Operational Performance Look Like?
Boston Scientific’s (BSX) gross income is expected to increase by 9.26% from $1.58 billion in the third quarter of fiscal 2017 to $1.73 billion in the third quarter of fiscal 2018. Its gross margin is expected to expand from 71.33% for the third quarter of fiscal 2017 to 71.95% for the third quarter of fiscal 2018.
Wed, 17 Oct 2018
15:57:58 +0000
Barclays Takes Action on Health Care Stocks
The firm has initiated coverage of Abbott Labs, Boston Scientific, Medtronic, Stryker and others
Tue, 16 Oct 2018
14:47:02 +0000
What's in Store for Cerner (CERN) This Earnings Season?
Cerner's (CERN) third-quarter 2018 results are likely to be hurt by soft segmental results; guidance promising.
Fri, 12 Oct 2018
14:23:02 +0000
Cerner's Millennium Platform Integrated at McLaren Hospital
Cerner's (CERN) Millennium HCIT platform sees a series of developments in 2018.
Fri, 12 Oct 2018
14:10:02 +0000
Can Baxter (BAX) Keep the Earnings Surprise Streak Alive?
Baxter (BAX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Thu, 11 Oct 2018
13:20:01 +0000
Baxter & ASPEN Launch PN Tools to Boost Clinical Nutrition
Baxter (BAX) and ASPEN's SmartPN lends the company a competitive edge in the MedTech space.
Thu, 11 Oct 2018
13:00:00 +0000
Investor Expectations to Drive Momentum within Materion, Iridium Communications, Natural Health Trends, Revance Therapeutics, Baxter International, and Alexion Pharmaceuticals — Discovering Underlying Factors of Influence
NEW YORK, Oct. 11, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Wed, 10 Oct 2018
12:00:00 +0000
Baxter and ASPEN Launch “SmartPN” Tools to Reinforce Appropriate Use of Parenteral Nutrition
Today the American Society for Parenteral and Enteral Nutrition (ASPEN), an organization which drives the science and practice of clinical nutrition, and Baxter International Inc. (BAX), a global leader in clinical nutrition, launched an educational video series on the appropriate use of parenteral nutrition (PN), as part of the organizations’ “SmartPN” collaboration to help reduce clinical malnutrition that was announced last year.
Sun, 07 Oct 2018
09:20:54 +0000
Suvretta Capital Management’s Return, AUM, and Holdings
Suvretta Capital Management is a young New York-based hedge fund founded by its current portfolio manager, Aaron Cowen, in 2012. Prior to founding Suvretta, Mr. Cowen honed his investment acumen working at two acclaimed large hedge funds: as a portfolio manager at Soros Fund Management, and as a CIO at SAC Capital. Prior to those positions, […]
Fri, 05 Oct 2018
14:15:02 +0000
ABT Stock Registered a 52-Week High in October
On October 4, Abbott Laboratories (ABT) ended the trading day at $71.82, down ~0.31% from the previous day’s close. The stock registered a 52-week high of $74.15 on October 1. Throughout the week, it’s fallen ~1.6%.
Fri, 05 Oct 2018
13:58:01 +0000
Zacks.com highlights: Lululemon Athletica, Malibu Boats, Surmodics and Baxter International
Zacks.com highlights: Lululemon Athletica, Malibu Boats, Surmodics and Baxter International
Fri, 05 Oct 2018
12:44:46 +0000
Analysts’ Recommendations on ABT Stock in October
Abbott Laboratories (ABT) offers market-leading products and solutions across its Medical Devices, Diagnostics, Nutrition, and Established Pharmaceuticals operating segments.
Thu, 04 Oct 2018
20:15:00 +0000
Baxter to Present at the 27th Annual Credit Suisse Healthcare Conference
Baxter International Inc. , a leading global medical products company, will present at the 27th Annual Credit Suisse Healthcare Conference in Scottsdale, Ariz. Jay Saccaro, Baxter’s chief financial officer, is scheduled to present on Wednesday, November 14, 2018 at 8:00 a.m.
Thu, 04 Oct 2018
14:28:02 +0000
Buy These 4 Efficient Stocks for Stellar Returns
A company with a favorable efficiency level is expected to provide stellar returns as it is believed to be positively correlated with price performance.
Wed, 03 Oct 2018
11:31:11 +0000
Baxter Collaborates With Mayo Clinic to Open Renal Care Center
Per the agreement, Baxter (BAX) and Mayo Clinic researchers to form an outpatient clinic for kidney disease management, home dialysis and in-center dialysis services.
Tue, 02 Oct 2018
13:00:00 +0000
Baxter and Mayo Clinic Announce Collaboration to Establish Renal Care Center of Excellence in the U.S.
Baxter International Inc. (BAX), a global innovator in renal care, and Mayo Clinic today announced a new collaboration to develop a renal care center of excellence in the U.S. The center will serve patients across the continuum of renal care — from chronic kidney disease (CKD) management through transplant — and drive better patient outcomes.
Tue, 02 Oct 2018
12:49:12 +0000
Baxter (BAX) Collaborates With USC CBC to Digitize Healthcare
Baxter's (BAX) efforts to digitize healthcare solutions are likely to fortify its foothold in the highly competitive MedTech industry.
Fri, 28 Sep 2018
12:13:00 +0000
Baxter Collaborates with University of Southern California Center for Body Computing to Advance Digital Health Solutions
Baxter International Inc. (BAX), a leading global medical products company, announced today a collaboration with the University of Southern California (USC) Center for Body Computing (CBC) to research and develop innovative digital solutions designed to help save and sustain lives. The association will bring together leaders from USC and Baxter who will evaluate access to and quality of care in patient populations, and to advance creative, technology-driven approaches to better serve patients and clinicians in the hospital and beyond. “Baxter has a long history of innovation in healthcare, and we see digital health providing an opportunity to significantly improve patient outcomes as well as enhance our technology offerings,” said Sumant Ramachandra, M.D., Ph.D., senior vice president, chief science and technology officer, Baxter.



"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "I absolutely LOVE ValueForum, and consider this site the most important tool I have for investing and/or trading because of the incredible information at just one site. I have learned so much from reading messages posted here that I recommend to the new comer to select an area of investing that is of interest and then read those posts starting with most current. I am sure you will gain information and learn techniques that can be applied to other areas/sectors of investing. This is an 'Invaluable' forum." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
 
Nothing in ValueForum.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ValueForum.com. ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards